nrt chart, page-3

forget the charts........we have finally reached human trials.....lets see how good this drug (phenoxidial) is......the reward to loss ratio is very attractive...........could be over $100 in 24months or back to $1 ......this is what i look at,and like ..hold a 1000 shares and forget about them..who know's.....

let me tell you this is a very tight lipped company ....you notice oppenhiemer funds owe about 14% of novogen......